Owners Weigh Sale Of Turkey’s Biofarma Pharmaceutical Industry Co Inc., Sources Say; In Deal Potentially Worth More Than $500 Million

Reuters -- An arm of Citigroup (C.N) and two other investors are mulling a sale of copycat drugmaker Biofarma, people familiar with the matter said, in what could be Turkey's biggest healthcare deal.